Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study will enroll patients who have a diagnosis of locally advanced, unresectable or
metastatic soft tissue or bone sarcoma (except gastrointestinal stromal tumors and Kaposi's
sarcoma) from any site.
Phase:
Early Phase 1
Details
Lead Sponsor:
Varun Monga, MD
Collaborators:
St. Baldrick's Foundation University of Iowa University of Iowa Adolescent and Young Adult (AYA) Cancer Program